Steven Cohen Acumen Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

  • $36.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$3.75 - $6.65 $14,827 - $26,294
3,954 New
3,954 $16,000
Q3 2022

Nov 14, 2022
BUY
$4.44 - $10.48 $181,755 - $429,009
40,936 New
40,936 $411,000
Q2 2022

Aug 15, 2022
SELL
$3.08 - $4.88 $169,566 - $268,663
-55,054 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$3.91 - $6.73 $215,261 - $370,513
55,054 New
55,054 $215,000

Others Institutions Holding ABOS

# of Institutions
78
Shares Held
41.8M
Call Options Held
57.7K
Put Options Held
749K
View Full List

About Acumen Pharmaceuticals, Inc.

ABOS Quotes by TradingView
  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $74.9M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email